product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Galactosylceramidase/GALC Protein, CF
catalog :
7310-GH-005
quantity :
5 ug
price :
499 USD
more info or order :
citations: 3
Reference
Babcock M, Mikulka C, Wang B, Chandriani S, Chandra S, Xu Y, et al. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. Sci Rep. 2021;11:14486 pubmed publisher
Akiyama H, Ide M, Nagatsuka Y, Sayano T, Nakanishi E, Uemura N, et al. Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol. J Biol Chem. 2020;295:5257-5277 pubmed publisher
Ullal A, Pham H, Singh R, Ross P, Graham C, Norton S, et al. Fluorimetric assay with a novel substrate for quantification of galactocerebrosidase activity in dried blood spot specimens. Pract Lab Med. 2020;18:e00141 pubmed publisher
product information
brand :
R&D Systems
master code :
7310-GH
SKU :
7310-GH-005
product name :
Recombinant Human Galactosylceramidase/GALC Protein, CF
description :
The Recombinant Human Galactosylceramidase/GALC Protein, CF from R&D Systems is derived from CHO. The Recombinant Human Galactosylceramidase/GALC Protein, CF has been validated for the following applications: Enzyme Activity.
target :
Galactosylceramidase/GALC
category :
Proteins and Enzymes
unit sizes :
5 ug
buffer :
Supplied as a 0.2 µm filtered solution in MES, NaCl and Glycerol.
conjugate :
Unconjugated
purity :
>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
species :
Human
observed molecular weight :
70-85 kDa, reducing conditions
theoretical molecular weight :
74 kDa
gene symbol :
GALC
details of functionality :
Measured by its ability to cleave a fluorogenic substrate, 4-Methylumbelliferyl-beta-D-galactopyranoside. The specific activity is 550 pmol/min/ug, as measured under the described conditions.
endotoxin note :
<1.0 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
NP_000144
applications :
Enzyme Activity
source :
CHO-derived Recombinant Human Galactosylceramidase/GALC Protein, CF
USD :
499 USD
alt names :
EC 3.2.1.46, galactocerebrosidase, Galactocerebroside beta-galactosidase, Galactosylceramidase, galactosylceramidase (Krabbe disease), Galactosylceramide beta-galactosidase, galactosylceraminidase, GALC, GALCERase
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.